Iright
BRAND / VENDOR: Biolegend

Biolegend, 424401, True-Nuclear™ Transcription Factor Buffer Set, 120tests

CATALOG NUMBER: 424401
Precio habitual$0.99
/
Los gastos de envío se calculan en la pantalla de pagos.
  • In stock, ready to ship

  • Pedido pendiente, envío pronto

Este sitio está protegido por hCaptcha y se aplican la Política de privacidad de hCaptcha y los Términos del servicio.

Product Description

BioLegend's True-Nuclear™ Transcription Factor Buffer Set has been specially formulated for intracellular staining with minimum effect on the surface fluorochrome staining. See the advantages of True-Nuclear™ Transcription Factor Buffer Set in this brief webinar: biolegend.com/true_nuclear_webinar . Caution : The True-Nuclear™ Transcription Factor Buffer Set contains paraformaldehyde, which is toxic and mutagenic. Please handle with caution. Wear gloves, lab coats, and necessary protection to avoid direct contact.
120tests
Storage & Handling: Store between 2°C and 8°C. Do not freeze.
Application: ICFC - Quality tested
Recommended Usage: Prepare fresh Transcription Factor Fix working solution by diluting the 4X Fix Concentrate (1 part) with the Fix Diluent (3 parts). 1 mL of the 1X Fix working solution is needed for each tube. Prepare a 1X working solution of the Perm Buffer by diluting the 10X Perm Buffer with distilled water. 6.5 mL of 1X Perm Buffer is needed for each sample of tube. NOTE: The 10X Perm Buffer may have crystallization or precipitation when it is stored at 2-8°C; however, this is normal and does not affect the buffer's performance. If there is a heavy precipitation observed after dilution to 1X working solution, it can be filtered to clarify the solution.
Application Notes: Buffer Set Contents: True-Nuclear™ 4X Fix Concentrate (30 mL) True-Nuclear™ Fix Diluent (100 mL) True-Nuclear™ 10X Perm Buffer (100 mL)
Additional Product Notes: View more applications data using this product to stain Veri-Cells™ lyophilized control cells, to detect transcription factors, and to study TIGIT in our Scientific Poster Library.
Product Citations: Ogawa T, et al. 2020. J Immunol. 205:907. PubMed Wang L, et al. 2019. Front Pharmacol. 1.342361111. PubMed Shen M, et al. 2022. Adv Sci (Weinh). 9:e2203523. PubMed Cook ME, et al. 2022. Sci Immunol. 7:eabo0981. PubMed Whyte CE, et al. 2022. Curr Protoc. 2:e589. PubMed Lao L, et al. 2023. Cancer Immunol Res. 11:320. PubMed Li Y, et al. 2023. Adv Mater. 35:e2208923. PubMed Schwarz A, et al. 2023. Front Immunol. 14:1038689. PubMed Kozlovski S, et al. 2023. Front Immunol. 13:1041552. PubMed Yi X, et al. 2023. Signal Transduct Target Ther. 8:107. PubMed Martins Nascentes Melo L, et al. 2023. J Immunother Cancer. 11:. PubMed McKenzie C, et al. 2023. Mol Ther Nucleic Acids. 32:603. PubMed Wu C, et al. 2023. Cancer Metab. 11:7. PubMed Adu-Berchie K, et al. 2023. Nat Commun. 14:3546. PubMed Ajith A, et al. 2021. Front Immunol. 12:687715. PubMed Manso BA, et al. 2021. STAR Protoc. 2:100485. PubMed Wu HJ, et al. 2021. Nat Commun. 12:4897. PubMed Zeng N, et al. 2022. EMBO Rep. 23:e53302. PubMed Douglass SM, et al. 2021. Cancer Res. 81:658. PubMed Capelle CM, et al. 2022. Immunology. 165:428. PubMed Ellis GI, et al. 2022. Cell Rep Med. 3:100614. PubMed Grant NL, et al. 2022. Cell Rep. 39:110826. PubMed Hu M, et al. 2022. Int J Mol Sci. 23: . PubMed Jou E, et al. 2022. Sci Immunol. 7:eabn0175. PubMed Yu H, et al. 2022. Hematol Oncol. 40:894. PubMed Ogishi M, et al. 2023. J Exp Med. 220: . PubMed Isildar B, et al. 2022. Inflamm Regen. 42:55. PubMed Noman MZ, et al. 2022. Front Immunol. 13:980704. PubMed He Y, et al. 2022. Front Immunol. 13:986202. PubMed Ishii T, et al. 2022. Cell Death Discov. 8:480. PubMed Chen X, et al. 2022. J Extracell Vesicles. 11:e12279. PubMed Weng S, et al. 2022. Front Immunol. 13:1025931. PubMed Landshammer A, et al. 2023. Elife. 12: . PubMed Vyas M, et al. 2023. Front Immunol. 13:1098445. PubMed Wang L, et al. 2023. Oxid Med Cell Longev. 2023:6480848. PubMed Rustagi Y, et al. 2022. Diabetes. 71:1149. PubMed Zander R, et al. 2022. Immunity. 55:475. PubMed de Lemos L, et al. 2022. Development. 149:. PubMed Zhang M, et al. 2020. Nat Commun. 4.707638889. PubMed Li X, et al. 2022. Nat Commun. 13:2794. PubMed Otano I, et al. 2021. Nat Commun. 12:7296. PubMed Bujanover N, et al. 2021. Stem Cell Reports. 16:1884. PubMed Kim D, et al. 2021. Nanomicro Lett. 13:31. PubMed Hu HJ, et al. 2020. Cell Death Dis. 1.168055556. PubMed Guo R, et al. 2020. Nat Microbiol. 0.938194444. PubMed van der Heiden M, et al. 2020. Scand J Immunol. e13005:. PubMed Baram T, et al. 2021. Cells. 10:. PubMed Yang C, et al. 2021. J Immunother Cancer. 9:. PubMed Piepke M, et al. 2021. J Neuroinflammation. 18:265. PubMed Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed Webster MR, et al. 2020. Mol Cell. 77:633. PubMed Lin H, et al. 2020. Front Microbiol. 1.330555556. PubMed Fronik P, et al. 2021. J Med Chem. 64:12132. PubMed Woodruff MC, et al. 2020. Nat Immunol. 1.920833333. PubMed Helm M, et al. 2022. Life (Basel). 12:. PubMed Cortez JT, et al. 2020. Nature. 582:416. PubMed Prodinger J, et al. 2016. J Leukoc Biol. 99: 583-594. PubMed Noman MZ, et al. 2020. Sci Adv. 6:eaax7881. PubMed Paiva RS, et al. 2021. Eur J Immunol. 51:1968. PubMed Montel-Hagen A, et al. 2020. Cell Rep. 33:108320. PubMed Ng W, et al. 2021. Pharm Biol. 59:47:00. PubMed Tian X, et al. 2021. Annals of Translational Medicine. 9(9):781. PubMed Wei SC, et al. 2020. Cancer Discov. . PubMed Qi X, et al. 2019. Nat Med. 25:1225. PubMed Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed Guo W, et al. 2022. J Immunother Cancer. 10:. PubMed Shevyrev D, et al. 2021. Exp Ther Med. 209:21. PubMed Lopez DA, et al. 2022. Cell Rep. 41:111677. PubMed Freitas JT, et al. 2021. Pigment Cell Melanoma Res. 34:1084. PubMed Adamik J, et al. 2022. Nat Commun. 13:5184. PubMed He X, et al. 2021. Adv Sci (Weinh). 8:e2103023. PubMed Shiao SL, et al. 2021. Cancer Cell. 39:1202. PubMed Jarjour NN, et al. 2019. Nat Immunol. 1.310416667. PubMed de Andrade LF, et al. 2019. JCI Insight. 4:e133103. PubMed Pucella JN, et al. 2019. J Immunol. 202:1383. PubMed Synn CB, et al. 2022. Clin Transl Immunology. 11:e1364. PubMed Bunting MD, et al. 2022. Sci Adv. 8:eabk3327. PubMed Swartz AM, et al. 2022. Curr Protoc. 2:e410. PubMed Woodruff M, et al. 2020. medRxiv. . PubMed Goldfarb Y, et al. 2021. J Exp Med. 218:. PubMed Wiarda JE, et al. 2022. Life Sci Alliance. 5:. PubMed Ellis GI, et al. 2022. STAR Protoc. 3:101784. PubMed Qiao J, et al. 2019. Cancer Cell. 35:901. PubMed Sendler M, et al. 2020. Gastroenterology. 158:253. PubMed Lundtoft C, et al. 2017. PLoS Pathogens. 13(6):e1006425. PubMed Lü X, et al. 2021. Exp Ther Med. 22:1005. PubMed Li Y, et al. 2021. Cell Death Dis. 12:1001. PubMed Hu HJ, et al. 2021. Cancer Immunol Immunother. 70:3541. PubMed Ye Z, et al. 2021. Nat Commun. 12:907. PubMed Bin L, et al. 2017. APMIS. 10.1111/apm.12748. PubMed Saito E, et al. 2019. Biomaterials. 222:119432. PubMed Kleiman E, et al. 2021. Sci Rep. 11:9561. PubMed Xu Q, et al. 2021. Theranostics. 11:1937. PubMed Mudd PA, et al. 2022. Cell. 185:603. PubMed Zhang R, et al. 2022. Front Pharmacol. 13:870848. PubMed Rasmussen TA, et al. 2022. Cell Rep Med. 3:100766. PubMed Xu L, et al. 2020. Nat Cell Biol. 1162:22. PubMed Wang G, et al. 2020. Nat Commun. 0.611111111. PubMed Mirlekar B, et al. 2022. Cell Rep Med. :100744. PubMed de Picciotto S, et al. 2022. Nat Commun. 13:3866. PubMed Fang F, et al. 2021. Cell Rep. 37:109981. PubMed Ye Z, et al. 2021. NPJ Aging Mech Dis. 7:4. PubMed Miyauchi K, et al. 2016. Nat Immunol. 17:1447-1458. PubMed Datlinger P, et al. 2017. Nat Methods. 10.1038/nmeth.4177. PubMed Jarjour NN, et al. 2020. J Immunol. 204:923. PubMed Oherle K, et al. 2020. Immunity. 275:52. PubMed Okuma A, et al. 2017. Nat Commun.. 10.1038/s41467-017-02281-x. PubMed Yao C, et al. 2018. Autophagy. 1.854861111. PubMed Minns D, et al. 2021. Nat Commun. 12:1285. PubMed Dhar P, et al. 2021. Commun Biol. 4:905. PubMed Zhao X, et al. 2022. iScience. 25:104690. PubMed Chen M, et al. 2019. Cell Stem Cell. 25:501. PubMed Chen C, et al. 2020. Front Cell Neurosci. 14:8. PubMed Feng Y, et al. 2019. Stem Cell Res Ther. 0.479166667. PubMed Chen Y, et al. 2022. Nat Commun. 13:4468. PubMed Capelle CM, et al. 2021. Immunohorizons. 5:711. PubMed Lone W, et al. 2021. Clin Cancer Res. 27:6039. PubMed Chen Y, et al. 2021. Nat Immunol. 22:996. PubMed Bajaña S, et al. 2022. iScience. 25:103732. PubMed Alhudaithi SS, et al. 2020. Mol Pharm. 17:4691. PubMed Zhou H, et al. 2021. Cell Death Discov. 7:332. PubMed Andricovich J, et al. 2016. J Clin Invest. 126:905-20. PubMed Yang X, et al. 2021. Bioact Mater. 3150:6. PubMed Wang YJ, et al. 2021. Sci Rep. 11:8054. PubMed Wang R, et al. 2022. J Immunother Cancer. 10:. PubMed Zhong C, et al. 2021. J Virol. 95:e0092521. PubMed Smith KJ, et al. 2022. PLoS Biol. 20:e3001554. PubMed Zhu P, et al. 2022. Cell Commun Signal. 20:121. PubMed Zhao J, et al. 2021. Front Oncol. 10:621092. PubMed Prosser A, et al. 2021. STAR Protoc. 2:100810. PubMed Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed Gonzalez MM, et al. 2021. J Clin Invest. 131:. PubMed Vora AA, et al. 2021. STAR Protocols. 2(2):100565. PubMed Zeng Y, et al. 2019. FASEB J. 33:6596. PubMed Moritsch S, et al. 2022. Oncoimmunology. 11:2127271. PubMed Wang H, et al. 2022. J Cancer. 13:2126. PubMed Zhang L, et al. 2021. Mol Ther. 29:744. PubMed
Cell Type: Tregs
Biology Area: Immunology, Transcription Factors
Molecular Family: Nuclear Markers
Gene ID: NA
Regulatory Status: RUO
Other Names: Transcription Factor Fixation/Permeabilization Buffer Set


Order Guidelines

1. Price & Stock Available on Request. 📧Click to send email to: service@iright.com

2. Please DO NOT make payment before confirmation.

3. Minimum order value of $1,000 USD required.

Collaboration

Tony Tang

📧Email: Tony.Tang@iright.com

📱Mobile/WhatsApp/Wechat: +86-17717886924